MedTrace Logo

The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study

NCT00506532 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2007-07-25

No results posted yet for this study

Summary

1. Working Hypothesis:

The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients.
2. Aims of the Study:

The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients.

Conditions

  • Lung Transplantation
  • Primary Graft Dysfunction

Interventions

DRUG

Surfactant (calfactant)

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • MordechaI R Kramer, Prof · Pulmonary Institute Rabin Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2008-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00506532 on ClinicalTrials.gov